Frost & Sullivan: DeepSeek leads healthcare transformation, with ethical guidelines being indispensable

Integrating the DeepSeek artificial intelligence model into digital healthcare systems will significantly improve the efficiency and accuracy of existing AI healthcare solutions and play a positive role in promoting the digitization and assetization of smart healthcare in China. Specifically, DeepSeek can more accurately diagnose diseases and formulate treatment plans through deep learning and big data analysis, thereby improving the quality of medical services. In addition, the artificial intelligence model can also optimize resource allocation through intelligent means, enhancing the capabilities and efficiency of primary healthcare services, which will directly help solve the "impossible triangle" problem in healthcare services—i.e., the balance between cost, quality, and accessibility. From a healthcare technology perspective, the introduction of DeepSeek also provides strong data analysis support for big health research, thereby accelerating the transformation of scientific research achievements and promoting innovation and progress in medical technology.

For example, in medical imaging analysis, DeepSeek can accurately identify tumors and lesions, assisting doctors in making comprehensive diagnoses and significantly improving diagnostic accuracy and efficiency. In terms of personalized treatment plan formulation, DeepSeek provides customized treatment recommendations for patients by analyzing their genetic information and medical history through "precision medicine," enhancing treatment effects and reducing side effects. In addition, in clinical trial design, DeepSeek can also provide more clinical advice for pharmaceutical companies and doctors, accelerating the process of new drug research and development. These achievements not only improve the quality and efficiency of healthcare services but also bring innovative solutions to the healthcare industry, promoting the digital transformation of the entire industry.

With the widespread application of large model technologies such as DeepSeek, the AI healthcare market is undergoing a major transformation. In the past, AI healthcare mainly relied on single data sources, but now it is developing towards integrating multiple data sources (such as text, imaging, genetics, etc.). This transformation enables doctors to diagnose diseases more accurately and customize personalized treatment plans for patients. At the same time, the level of intelligence and automation of medical processes will also be significantly improved. Real-time monitoring data, automatic decision assistance, and cross-field cooperative innovation will jointly create a new ecosystem centered on data-driven and intelligent decision-making.

In this process, the application scope of AI is also constantly expanding. It not only has its advantages in the fields of healthcare and pharmaceutical services but is gradually penetrating into residents' daily lives, playing an increasingly important role in areas such as health management and medical insurance. It can be said that AI healthcare is moving towards a new development stage.

The main characteristics of this new stage include the efficient integration of multiple data sources, the popularization of personalized precision medicine, the application of intelligent automation processes, and the deep integration of medical research and clinical practice. However, with the rapid development of technology, issues such as data privacy protection, system security, and model interpretability have become more important. This requires the entire industry to pay more attention to compliance and ethics while pursuing technological innovation, striving to build an efficient and trustworthy future healthcare system.

Driven by advanced models such as DeepSeek, the commercialization of AI healthcare is expected to make new breakthroughs in multiple aspects such as product innovation, application scenario expansion, and industrial integration. In terms of product innovation, AI technology is breaking through the limitations of traditional manual work. For example, medical virtual humans are playing an increasingly important role in hospital and out-of-hospital scenarios with their intelligent services. Enterprises can achieve profitability by selling services or licensing technology. In terms of application scenario expansion, the application scope of AI healthcare is also constantly expanding. For example, in home hospice care services, combined with intelligent monitoring devices, AI healthcare can cooperate with elderly care and insurance institutions to meet the needs of hospice care while realizing commercial value.

At the level of industrial integration, the combination of AI healthcare with other fields has also brought new opportunities. For example, the linkage between AI healthcare and the metaverse has created virtual healthcare platforms that generate revenue by charging platform usage fees and virtual item sales fees, bringing innovation to medical training and experience. At the same time, the combination of AI healthcare with fintech has given rise to innovative medical financial services. By analyzing data with DeepSeek, on the one hand, it can provide personalized product plans for patients and medical institutions, and on the other hand, based on these innovative product plans, it can also combine innovative payment, diversified finance, and other market elements and tools to match better commercial implementation plans and achieve greater commercial value expression. These breakthroughs not only promote the progress of AI healthcare technology products but also bring new growth points to enterprises. More importantly, through the combination of product technology and market commercialization, they will not only benefit patients but also promote further reform of the supply side of medical technology and promote the high-quality development of the entire medical industry.

In the current context of rapid development of AI healthcare technology, traditional healthcare enterprises have both faced huge opportunities and significant challenges. To maintain competitiveness in the fierce market competition, enterprises can start from multiple aspects, making comprehensive layouts and transformations.

First of all, technological innovation is key. Traditional healthcare enterprises should actively embrace artificial intelligence technology and regard it as an important means to improve the efficiency and quality of medical services. They can cooperate with leading AI companies or increase their own R&D investment in the AI field to apply AI technology to various aspects of healthcare.

Technological innovation cannot do without data support, and traditional healthcare enterprises urgently need to attach importance to data accumulation and management. Data security and privacy protection are also crucial. Enterprises must strictly abide by laws and regulations to ensure the safety and compliance of patient information and prevent legal and reputational risks brought about by data leakage.

To develop technology, talent is the core. Traditional healthcare enterprises need to build a composite team that understands both healthcare and AI. In addition, the transformation of service models is also an important part of improving user experience. Traditional healthcare enterprises can use AI technology to develop remote medical platforms, breaking through time and space limitations, providing patients with online consultations, health consultations, chronic disease management and other services, making it more convenient for patients to obtain medical services.

Traditional healthcare enterprises should also strengthen ecological cooperation for the implementation of AI technology. By strengthening cooperation with medical institutions, research institutes, technology companies and other parties, they can build an open and win-win ecosystem. Through resource sharing and complementary advantages, enterprises can accelerate the implementation of AI technology in the medical field and take the initiative in formulating industry standards and innovating business models.

Policies and regulations are the guarantee for enterprise development. With the rapid development of AI healthcare technology, governments and regulatory agencies around the world are continuously improving relevant laws and regulations. Traditional healthcare enterprises need to pay close attention to policy changes to ensure that business is carried out under compliance. At the same time, enterprises should also actively participate in formulating industry standards, promote the rationalization and standardization of policies, create a good external environment for their own development, and avoid normal operations being affected by policy risks.

Generally speaking, traditional healthcare enterprises can build their core advantages through efforts in multiple aspects such as technological innovation, data-driven development, talent cultivation, service model transformation, and ecological cooperation, thereby maintaining competitiveness in the AI healthcare era, achieving sustainable development and transformation and upgrading.

The application of large models such as DeepSeek has brought new investment opportunities to the AI healthcare field in China and even globally, and has significantly attracted new investment attraction and confidence from the capital market. Sub-sectors such as medical imaging analysis, personalized treatment plans, remote medicine, intelligent assisted diagnosis, and drug research and development will become hotspots for AI healthcare investment. The innovative applications in these fields can not only attract investment enthusiasm from the capital market, facilitate financing for innovative enterprises, accelerate the innovation and commercialization process of AI products in the medical field, but also further accelerate the overseas expansion of local AI healthcare innovation businesses in China. Against this background, investment opportunities around product, business, and service overseas expansion will also grow rapidly in the future.

In the hotspots for AI healthcare investment, medical imaging analysis is considered one of the most promising sub-sectors. With the continuous progress of deep learning technology, AI has achieved remarkable results in medical imaging diagnosis. It can quickly and accurately identify lesions and abnormalities, assisting doctors in making more accurate diagnoses. The technology maturity in this field is relatively high, market demand is strong, and application scenarios are extensive, covering the whole process from early screening to disease diagnosis and treatment monitoring. In addition, the commercialization prospects of medical imaging analysis are broad. It can not only improve the efficiency and quality of medical services but also bring considerable economic benefits to healthcare technology enterprises.

Therefore, medical imaging analysis has great potential in attracting investment, promoting technological innovation, and realizing commercial application. It is expected to become an important growth point in the AI healthcare field. Other hotspots include the innovative accumulation and application of big health medical data assets, artificial intelligence drug research and development support, etc. All fields around intelligent data assets and intelligent algorithms will become sub-sectors worthy of attention.

While paying attention to technological innovation and application innovation, investors should also attach great importance to ethical and moral issues and privacy protection. Under the rapid development of AI healthcare driven by large models, innovative artificial intelligence enterprises should ensure that in technology development and application, they have followed strict ethical guidelines, actively taken measures to avoid data abuse and algorithm bias, and actively cooperated with regulatory agencies' ethical reviews. At the same time, enterprises need to establish a strong data protection mechanism to ensure the safety and privacy of patient information. For investors, actively adopting the above business development principles and promoting fair healthcare in the long term often makes business risks more controllable. Investors should also pay attention to policy changes to ensure that the future commercialization strategies of research products can meet relevant legal requirements, thereby achieving long-term sustainable investment returns.